We mean this sincerely: researchers pursuing BPC-157 gastroparesis studies are working on a genuinely novel therapeutic angle, but the leap from 'works in rats' to 'safe and effective in humans' requires Phase I safety trials, Phase II dose-finding studies, and Phase III controlled efficacy comparisons against existing treatments like metoclopramide or domperidone
[8] Li, C., Tong, H., Yan, Q., Tang, S., Han, X., Xiao, W., & Tan, Z
Of course, the dosage can change depending on its effectiveness
Companies of all sizes have poured their resources into this field, driving the pace of drug iteration to a level never before seen in the history of human medicine